Clinical Trials Logo
  1. Home
  2. Cardio-Renal Syndrome
  3. NCT02664246

Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method

Cardio-Renal Syndrome Clinical Trial

Official title:
Chinese People's Liberation Army General Hospital

Clinical Trial Summary

This review article have included about ten thousand patients undergoing percutaneous coronary intervention (PCI), aim to identify the incidence of CIN in actual, find some new risk factors and the protecting methods for these factors.

Clinical Trial Description

About ten thousand patients undergoing percutaneous coronary intervention (PCI) from 2010 to 2015 are included in this study. We collect the data about the SCr of the patients before and after percutaneous coronary intervention, and define CIN as an increase in SCr of 0.5 mg/dl or 25% from baseline between 48 and 72 h after contrast medium exposure. Besides we obtain the data including clinical characteristics, laboratory data (blood and urine tests) for all the patients. The statistical analysis will find some new risk factors. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02664246
Study type Observational
Source Chinese PLA General Hospital
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date January 2016
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05053893 - Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Recruiting NCT04170855 - Kidney Sodium Content in Cardiorenal Patients N/A
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Withdrawn NCT02085668 - Renal Denervation in Patients With Chronic Heart Failure N/A
Terminated NCT02772146 - A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure N/A
Recruiting NCT02846337 - Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome N/A
Active, not recruiting NCT02502981 - Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Phase 4
Recruiting NCT04947670 - A Prospective, Multicenter, Randomized, Blinded, Sham-controlled, Feasibility Study of Renal Denervation in Patients With Chronic Heart Failure N/A
Not yet recruiting NCT05368766 - Predictive Value of Venous Excess Ultrasound Score in Management of Cardiorenal Patients
Withdrawn NCT02959281 - Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I N/A
Completed NCT04407936 - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention
Completed NCT05050877 - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II
Recruiting NCT03628443 - Cardiorenal Risk Stratification Pilot Study
Recruiting NCT02343393 - Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study Phase 3
Completed NCT03219996 - Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis N/A
Completed NCT04145635 - The Aortix CRS Pilot Study N/A
Completed NCT02405377 - Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy N/A
Recruiting NCT05677100 - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure N/A
Completed NCT02831907 - Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery N/A